open access

Ahead of Print
Research paper
Published online: 2023-10-06
Get Citation

Neonatal outcomes for women diagnosed with cancer during pregnancy — single-center study

Beata Pawlus12, Jerzy Zwolinski12, Urszula Koneczna12, Grzegorz Pawlus3, Agnieszka Kordek4
·
Pubmed: 37801621
Affiliations
  1. Specialist Hospital of Holy Family, Warsaw, Poland
  2. Faculty of Medicine, Lazarski University, Warsaw, Poland, Poland
  3. Department of Physical Education, Academy of Physical Education and Sport, Gdansk, Poland
  4. Department of Neonatology and Neonatal Intensive Care Pomeranian Medical University in Szczecin, Poland

open access

Ahead of Print
ORIGINAL PAPERS Obstetrics
Published online: 2023-10-06

Abstract

Pregnancy complicated by cancer is one of the most serious challenges of modern perinatology. The increasing number of cancers diagnosed and treated during pregnancy requires a multidisciplinary approach to optimize the treatment of the person who is pregnant and deliver a healthy child. The aim of the study is to analyze the course of the neonatal period in children of mothers suffering from cancer during pregnancy, treated in a specialist hospital for women and children. Being diagnosed with cancer during pregnancy significantly increases the risk of premature delivery, prematurity and intrauterine growth restriction. Our own observations show no significant differences during the neonatal period in children of mothers suffering from a malignant tumor during pregnancy compared to children of healthy mothers. This applies to both full-term and premature babies. Modern treatment of malignant tumors during pregnancy seems to be safe for the fetus and newborn. It is optimal to conduct oncological, obstetric and neonatological treatment in one center. It seems advisable to conduct long-term follow-up observations in children of pregnant people with cancer. Since the described groups of patients and their newborns are small and heterogeneous, in order to develop appropriate standards, it is recommended to report these cases to central registers.

Abstract

Pregnancy complicated by cancer is one of the most serious challenges of modern perinatology. The increasing number of cancers diagnosed and treated during pregnancy requires a multidisciplinary approach to optimize the treatment of the person who is pregnant and deliver a healthy child. The aim of the study is to analyze the course of the neonatal period in children of mothers suffering from cancer during pregnancy, treated in a specialist hospital for women and children. Being diagnosed with cancer during pregnancy significantly increases the risk of premature delivery, prematurity and intrauterine growth restriction. Our own observations show no significant differences during the neonatal period in children of mothers suffering from a malignant tumor during pregnancy compared to children of healthy mothers. This applies to both full-term and premature babies. Modern treatment of malignant tumors during pregnancy seems to be safe for the fetus and newborn. It is optimal to conduct oncological, obstetric and neonatological treatment in one center. It seems advisable to conduct long-term follow-up observations in children of pregnant people with cancer. Since the described groups of patients and their newborns are small and heterogeneous, in order to develop appropriate standards, it is recommended to report these cases to central registers.

Get Citation

Keywords

newborn; pregnancy; cancer

About this article
Title

Neonatal outcomes for women diagnosed with cancer during pregnancy — single-center study

Journal

Ginekologia Polska

Issue

Ahead of Print

Article type

Research paper

Published online

2023-10-06

Page views

222

Article views/downloads

152

DOI

10.5603/gpl.95610

Pubmed

37801621

Keywords

newborn
pregnancy
cancer

Authors

Beata Pawlus
Jerzy Zwolinski
Urszula Koneczna
Grzegorz Pawlus
Agnieszka Kordek

References (26)
  1. Dalmartello M, Negri E, La Vecchia C, et al. Frequency of Pregnancy-Associated Cancer: A Systematic Review of Population-Based Studies. Cancers (Basel). 2020; 12(6).
  2. Kontopodi E, Arslanoglu S, Bernatowicz-Lojko U, et al. "Donor milk banking: Improving the future". A survey on the operation of the European donor human milk banks. PLoS One. 2021; 16(8): e0256435.
  3. Silverstein J, Post AL, Chien AJo, et al. Multidisciplinary Management of Cancer During Pregnancy. JCO Oncol Pract. 2020; 16(9): 545–557.
  4. Cubillo A, Morales S, Goñi E, et al. Multidisciplinary consensus on cancer management during pregnancy. Clin Transl Oncol. 2021; 23(6): 1054–1066.
  5. Boere I, Lok C, Poortmans P, et al. Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalities. Best Pract Res Clin Obstet Gynaecol. 2022; 82: 46–59.
  6. Maggen C, Wolters VE, Cardonick E, et al. International Network on Cancer, Infertility and Pregnancy (INCIP). Pregnancy and Cancer: the INCIP Project. Curr Oncol Rep. 2020; 22(2): 17.
  7. Greiber IK, Viuff JH, Mellemkjaer L, et al. Cancer in pregnancy and the risk of adverse pregnancy and neonatal outcomes: A nationwide cohort study. BJOG. 2022; 129(9): 1492–1502.
  8. Hepner A, Negrini D, Hase EA, et al. Cancer During Pregnancy: The Oncologist Overview. World J Oncol. 2019; 10(1): 28–34.
  9. Korenaga TRK, Tewari KS. Gynecologic cancer in pregnancy. Gynecol Oncol. 2020; 157(3): 799–809.
  10. Puzzi-Fernandes C, Surita FG, Schettini CS, et al. Awareness towards an increasing concern during pregnancy: maternal and perinatal outcomes of women with cancer. Am J Obstet Gynecol MFM. 2020; 2(3): 100168.
  11. Yp Z, J D, Xw Z, et al. Maternal and neonatal outcomes of cancer during pregnancy: a multi-center observational study. J Cancer. 2019; 10(23): 5727–5734.
  12. Folsom SM, Woodruff TK. Good news on the active management of pregnant cancer patients. F1000Res. 2020; 9.
  13. Peccatori FA, Migliavacca Zucchetti B, Buonomo B, et al. Lactation during and after Breast Cancer. Adv Exp Med Biol. 2020; 1252: 159–163.
  14. Monti M, D'Aniello D, Scopelliti A, et al. Relationship between cervical excisional treatment for cervical intraepithelial neoplasia and obstetrical outcome. Minerva Obstet Gynecol. 2021; 73(2): 233–246.
  15. Bogani G, Ditto A, Pinelli C, et al. Ten-year follow-up study of long-term outcomes after conservative surgery for early-stage ovarian cancer. Int J Gynaecol Obstet. 2020; 150(2): 169–176.
  16. Kalampokas E, Vlahos N, Kalampokas T, et al. Common Malignancies During Pregnancy: A Comprehensive Review. Cancer Diagn Progn. 2021; 1(3): 103–109.
  17. Ray JG, Vermeulen MJ, Bharatha A, et al. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. JAMA. 2016; 316(9): 952–961.
  18. Bhurosy T, Niu Z, Heckman CJ. Breastfeeding is Possible: A Systematic Review on the Feasibility and Challenges of Breastfeeding Among Breast Cancer Survivors of Reproductive Age. Ann Surg Oncol. 2021; 28(7): 3723–3735.
  19. Maggen C, Dierickx D, Cardonick E, et al. International Network on Cancer Infertility Pregnancy (INCIP). Maternal and neonatal outcomes in 80 patients diagnosed with non-Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and Pregnancy. Br J Haematol. 2021; 193(1): 52–62.
  20. Esposito G, Franchi M, Dalmartello M, et al. Obstetric and neonatal outcomes in women with pregnancy associated cancer: a population-based study in Lombardy, Northern Italy. BMC Pregnancy Childbirth. 2021; 21(1): 31.
  21. Maxwell CV, Al-Sehli H, Parrish J, et al. Breast Cancer in Pregnancy: A Retrospective Cohort Study. Gynecol Obstet Invest. 2019; 84(1): 79–85.
  22. Lu D, Ludvigsson JF, Smedby KE, et al. Maternal Cancer During Pregnancy and Risks of Stillbirth and Infant Mortality. J Clin Oncol. 2017; 35(14): 1522–1529.
  23. Maggen C, Wolters VE, Van Calsteren K, et al. International Network on Cancer, Infertility and Pregnancy (INCIP). Impact of chemotherapy during pregnancy on fetal growth. J Matern Fetal Neonatal Med. 2022; 35(26): 10314–10323.
  24. Sorokine A, Czuzoj-Shulman N, Abenhaim HA. Maternal and neonatal outcomes in women with a history of chemotherapy exposure: a population-based study of 8 million obstetric admissions. Arch Gynecol Obstet. 2023; 307(3): 747–753.
  25. Sella T, Exman P, Ren S, et al. Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis. Breast Cancer Res Treat. 2022; 194(3): 597–606.
  26. de Haan J, Verheecke M, Van Calsteren K, et al. International Network on Cancer and Infertility Pregnancy (INCIP). Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018; 19(3): 337–346.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl